1-15 of 15
Zhiming Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Xiao-Peng Tian, Shu-Yun Ma, Ken H. Young, Choon Kiat Ong, Yanhui Liu, Zhihua Li, Qiongli Zhai, Hui-Qiang Huang, Tongyu Lin, Zhiming Li, Zhong-Jun Xia, Liye Zhong, Huilan Rao, Mei Li, Jun Cai, Yuchen Zhang, Fen Zhang, Ning Su, Peng-Fei Li, Feng Zhu, Zijun Yidan Xu-Monette, Esther Kam Yin Wong, Jeslin Chian Hung Ha, Lay Poh Khoo, Le Ai, Runfen Cheng, Jing Quan Lim, Sanjay de Mel, Siok-Bian Ng, Soon Thye Lim, Qingqing Cai
Journal: Blood
Blood blood.2020010637.
DOI: https://doi.org/10.1182/blood.2020010637
Published: 2021
Includes: Supplemental data
Journal Articles

The Expression of Paks and Its Clinical Significance in T-Cell Lymphoblastic Lymphoma

Qingqing Cai, PhD, Ning Su, MM, Yu Fang, BMBS, Xu Chen, MDPhD, Xiaopeng Tian, MDPhD, Shuyun Ma, MM, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Tongyu Lin, MD PhD, Huiqiang Huang, MDPhD, Zhiming Li, MD PhD, Xueyi Pan, MDPhD, Yi Xia, MD PhD, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Hang Yang, MD PhD, Stephen Yang Liang, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
DOI: https://doi.org/10.1182/blood-2020-136975
Published: 2020
Journal Articles

Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic Malignancies

Yuqin Song, MD PhD, Wei Xu, MD PhD, Yongping Song, MD, Lihong Liu, MD, Song Lin, Zhiming Li, MD PhD, Ting Liu, MD PhD, Shuhua Yi, MD, Daobin Zhou, MD PhD, Mingzhi Zhang, MD, Yu Hu, MD, Jie Jin, MD PhD, Huaqiang Zhu, MD, Zhengguang Lu, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
DOI: https://doi.org/10.1182/blood-2020-140172
Published: 2020
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-136842
Published: 2020
Journal Articles

Chidamide Plus R-GemOx(rituximab, gemcitabine and oxaliplatin) Regimen As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Preliminary Analysis of a Multicenter, Single Arm, Phase II Study

Qingqing Cai, PhD, Hui Zhou, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Yudan Wu, MDPhD, Bingyi Wu, MDPhD, Hui Yang, MDPhD, Stephen Yang Liang, MDPhD, Ning Su, MM, Panpan Liu, MD PhD, Xuanye Zhang, MDPhD, Yi Xia, MD PhD, Shuyun Ma, MM
Journal: Blood
Blood (2020) 136 (Supplement 1): 52–53.
DOI: https://doi.org/10.1182/blood-2020-136993
Published: 2020
Journal Articles

Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas

Junning Cao, Zhiming Li, MD PhD, Jianfeng Zhou, MD PhD, Dongmei Ji, MD PhD, Weina Shen, PhD, Peng Sun, MD, Yu Wang, MD, Dengju Li, MD, Zhenya Hong, MDPhD, Gaoxiang Wang, MDPhD, Xianlin Duan, MD, Chen Yu, MD, Yu Cai, PhD, Weiguo Su, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
DOI: https://doi.org/10.1182/blood-2020-136013
Published: 2020
Journal Articles

Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, MD, Mingzhi Zhang, MD, Zhiming Li, MD PhD, Chunyan Ji, MD, Wei Xu, MD PhD, Ting Liu, MD PhD, Bing Xu, MD PhD, Xin Wang, MDPhD, Sujun Gao, Huilai Zhang, MD PhD, Yu Hu, MD, Yan Li, Ying Cheng, Haiyan Yang, MD PhD, Junning Cao, Zunmin Zhu, MD, Jianda Hu, MDPhD, Wei Zhang, Hongmei Jing, MD PhD, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-141781
Published: 2020
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
DOI: https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, Mingzhi Zhang, Zhiming Li, Chunyan Ji, Wei Xu, MD PhD, Ting Liu, MD, Bing Xu, Xin Wang, MD PhD, Sujun Gao, Huilai Zhang, MD, Yu Hu, Yan Li, Ying Cheng, Haiyan Yang, Junning Cao, MD, Zunmin Zhu, Jianda Hu, PhD, Wei Zhang, Hongmei Jing, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, Zhixin Xu, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 755.
DOI: https://doi.org/10.1182/blood-2019-126305
Published: 2019
Journal Articles

Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma

Weicheng Ren, Xiaofei Ye, Hong Su, Wei Li, Dongbing Liu, Mohammad Pirmoradian, Xianhuo Wang, Bo Zhang, Qiang Zhang, Longyun Chen, Man Nie, Yao Liu, Bin Meng, Huiqiang Huang, Wenqi Jiang, Yixin Zeng, Wenyu Li, Kui Wu, Yong Hou, Klas G. Wiman, Zhiming Li, Huilai Zhang, Roujun Peng, Shida Zhu, Qiang Pan-Hammarström
Journal: Blood
Blood (2018) 131 (24): 2670–2681.
DOI: https://doi.org/10.1182/blood-2017-11-817601
Published: 2018
Includes: Supplemental data
Journal Articles

Neutrophils Extracellular Traps Induced By Lymphoma-Derived IL-8 Could Promote Diffuse Large B Cell Lymphoma Progression

Man Nie, Linbing Yang, Xiwen Bi, Yu Wang, Peng Sun, Hang Yang, Panpan Liu, Zhiming Li, Yi Xia, Wenqi Jiang, Wenyu Li, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4029.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4029.4029
Published: 2017
Journal Articles

Pegaspargase Plus Gemcitabine, Oxaliplatin(P-Gemox) and Thalidomide Versus Aspermetdex Regimen for the Patients with Early or Advanced/Relapsed Extranodal Natural Killer/T Cell Lymphoma: Interim Analysis of a Prospective,Multicenter, Randomized, Phase III Non-Inferiority Clinical Trial

Yan Gao, Huiqiang Huang, MD, Yujing Zhang, Hang Su, Xiaoxiao Wang, Bing Bai, Yunhong Huang, Yuhuan Gao, Liping Su, MD, Xiaoxia Chu, Wenyu Li, Junyi Zhang, Qiaohua Zhang, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1819.
DOI: https://doi.org/10.1182/blood.V128.22.1819.1819
Published: 2016
Journal Articles

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Wei Zhao, Zheng Yan, Wenqi Jiang, MD PhD, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 1521.
DOI: https://doi.org/10.1182/blood.V126.23.1521.1521
Published: 2015
Journal Articles

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Zheng Yan, Wenqi Jiang, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 3936.
DOI: https://doi.org/10.1182/blood.V126.23.3936.3936
Published: 2015
Journal Articles

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Qingqing Cai, MD PhD, Kailin Chen, MD, Qirong Geng, MD, Guangzheng Zhong, MD, Jianping Li, MD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Wenqi Jiang, MD PhD, Zhiming Li, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1655.
DOI: https://doi.org/10.1182/blood.V124.21.1655.1655
Published: 2014